Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy

Reference

• Abdel-Salam FS, Mahmoud AA, Ammar HO, et al. (2016). Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate. J Liposome Res. [Epub ahead of print]. doi: 10.3109/08982104.2016.1149866
   PubMed Web of Science ®Google Scholar
• Abul Kalam M, Sultana Y, Ali A, et al. (2013). Part II: enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops. J Biomed Mater Res A 101:1828–36
   PubMed Web of Science ®Google Scholar
• Ali J, Fazil M, Qumbar M, et al. (2016). Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv 23:710–26
   PubMed Web of Science ®Google Scholar
• Amekyeh H, Billa N, Yuen KH, et al. (2015). A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats. AAPS PharmSciTech 16:871–7
   PubMed Web of Science ®Google Scholar
• Ansari Z, Miller D, Galor A. (2013). Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep 7:209–18
   PubMedGoogle Scholar
• Chhonker YS, Prasad YD, Chandasana H, et al. (2015). Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol 72:1451–8
   PubMed Web of Science ®Google Scholar
• de Campos AM, Diebold Y, Carvalho EL, et al. (2004). Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21:803–10
   PubMed Web of Science ®Google Scholar
• Di Colo G, Zambito Y, Burgalassi S, et al. (2004). Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin. Int J Pharm 273:37–44
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrín M, Sáez V, et al. (2007). Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 28:1553–64
   PubMed Web of Science ®Google Scholar
• Fukui H, Koike T, Saheki A, et al. (2003). A novel delivery system for amphotericin B with lipid nano-sphere (LNS). Int J Pharm 265:37–45
   PubMed Web of Science ®Google Scholar
• Ibrahim F, Gershkovich P, Sivak O, et al. (2013). Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats. Drug Dev Ind Pharm 39:1277–83
   PubMed Web of Science ®Google Scholar
• Kaur L, Jain SK, Manhas RK, et al. (2015). Nanoethosomal formulation for skin targeting of amphotericin B: an in vitro and in vivo assessment. J Liposome Res 25:294–307
   PubMed Web of Science ®Google Scholar
• la Fuente M, Raviña M, Paolicelli P, et al. (2010). Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 62:100–17
   PubMed Web of Science ®Google Scholar
• Li X, Nie SF, Kong J, et al. (2008). A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 363:177–82
   PubMed Web of Science ®Google Scholar
• Ludwig A. (2005). The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 57:1595–639
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhao J, Zhang X, et al. (2011). Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 403:185–91
   PubMed Web of Science ®Google Scholar
• Puglia C, Offerta A, Carbone C, et al. (2015). Lipid nanocarriers (LNC) and their applications in ocular drug delivery. Curr Med Chem 22:1589–602
   PubMed Web of Science ®Google Scholar
• Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of beta-blocking agents I: physiochemical factors. J Pharm Sci 72:1266–72
   PubMed Web of Science ®Google Scholar
• Shi W, Wang T, Xie L, et al. (2010). Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology 117:890–6
   PubMed Web of Science ®Google Scholar
• Short BG. (2008). Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol 36:49–62
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovova S, Gonzalez-Mira E, et al. (2010). Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr Eye Res 35:537–52
   PubMed Web of Science ®Google Scholar
• Suresh PK, Sah AK. (2014). Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions. Expert Opin Drug Deliv 11:1747–68
   PubMed Web of Science ®Google Scholar
• Tan TR, Hoi KM, Zhang P, et al. (2016). Characterization of a polyethylene glycol-amphotericin B conjugate loaded with free AMB for improved antifungal efficacy. PLoS One 11:e0152112
   PubMed Web of Science ®Google Scholar
• Tian B, Luo Q, Song S, et al. (2012). Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery. J Pharm Sci 101:1040–9
   PubMed Web of Science ®Google Scholar
• Tuncay Tanrıverdi S, Hilmioğlu Polat S, Yeşim Metin D, et al. (2016). Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation. J Liposome Res 26:163–73
   PubMed Web of Science ®Google Scholar
• Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, et al. (2014). Preparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nanostructured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci 63:204–15
   PubMed Web of Science ®Google Scholar
• Üstündağ-Okur N, Gökçe EH, Bozbıyık Dİ, et al. (2015). Novel nanostructured lipid carrier-based inserts for controlled ocular drug delivery: evaluation of corneal bioavailability and treatment efficacy in bacterial keratitis. Expert Opin Drug Deliv 12:1791–807
   PubMed Web of Science ®Google Scholar
• Verma P, Gupta RN, Jha AK, et al. (2013). Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide. Drug Deliv 20:269–76
   PubMed Web of Science ®Google Scholar
• Wagner ME, Rizvi SS. (2015). Novel method of niosome generation using supercritical carbon dioxide part I: process mechanics. J Liposome Res 25:334–46
   PubMed Web of Science ®Google Scholar
• Wang F, Chen L, Jiang S, et al. (2014). Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box–Behnken design. J Liposome Res 24:171–81
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu R, Sun X, et al. (2014). Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. Int J Nanomed 9:3987–98
   PubMed Web of Science ®Google Scholar
• Wang L, Sun S, Jing Y, et al. (2009). Spectrum of fungal keratitis in central China. Clin Exp Ophthalmol 37:763–71
   PubMed Web of Science ®Google Scholar
• Wang L, Luo Q, Lin T, et al. (2015). PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm 41:1204–12
   PubMed Web of Science ®Google Scholar